Stocks analysis

Analysis for ALGN

  • 📈 Growth — 20/30
  • 💰 Profitability — 18/20
  • 🏦 Financial Health — 18/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 4/10
Overall Score: 74/100

Summary:


📈 Growth & Financial Trajectory

From 8 quarters, ALIGN Technology demonstrates a steady trajectory with revenues expanding modestly from about $1,028.5M in 2024 Q2 to $1,056.2M in 2026 Q2, while net income rises from $96.6M to $108.3M. Gross margins remain robust, roughly in the 70% range, with latest quarters around 71–72%. Operating income stays strong, indicating favorable leverage despite muted top-line growth.

💰 Margins & Cash Flow

  • Gross margin typically around 70%, with quarterly values near 71–72%.
  • Operating margin remains solid, enabling net income growth alongside revenue.
  • Net cash flow from operating activities is positive in each quarter, generally in the low to mid hundreds of millions, while investing and financing activities show outflows, yielding mixed overall cash flow and solid liquidity.

🛡️ Balance Sheet & Liquidity

  • Assets run around $6.0–$6.4B; Liabilities about $2.2–$2.4B; Equity near $3.9–$4.2B.
  • Current ratio typically ~1.3–1.5, signaling stable short-term liquidity. Noncurrent liabilities are modest or nil in several periods, supporting financial resilience.

⚠️ Key Drivers & Risks

  • Drivers: Global orthodontics demand and Invisalign adoption; favorable product mix sustaining high margins.
  • Risks: Cyclicality of dental procedures and reimbursement dynamics; competitive pressures and valuation sensitivity.